166 related articles for article (PubMed ID: 28018297)
1. Mechanisms of Antibacterial Action of Quinoxaline 1,4-di-
Xu F; Cheng G; Hao H; Wang Y; Wang X; Chen D; Peng D; Liu Z; Yuan Z; Dai M
Front Microbiol; 2016; 7():1948. PubMed ID: 28018297
[TBL] [Abstract][Full Text] [Related]
2. The critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo.
Wang X; Martínez MA; Cheng G; Liu Z; Huang L; Dai M; Chen D; Martínez-Larrañaga MR; Anadón A; Yuan Z
Drug Metab Rev; 2016 May; 48(2):159-82. PubMed ID: 27285897
[TBL] [Abstract][Full Text] [Related]
3. ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro.
Huang XJ; Zhang HH; Wang X; Huang LL; Zhang LY; Yan CX; Liu Y; Yuan ZH
Chem Biol Interact; 2010 May; 185(3):227-34. PubMed ID: 20188712
[TBL] [Abstract][Full Text] [Related]
4. Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli.
Cheng G; Li B; Wang C; Zhang H; Liang G; Weng Z; Hao H; Wang X; Liu Z; Dai M; Wang Y; Yuan Z
PLoS One; 2015; 10(8):e0136450. PubMed ID: 26296207
[TBL] [Abstract][Full Text] [Related]
5. Further investigations into the genotoxicity of quinoxaline-di-N-oxides and their primary metabolites.
Liu Q; Zhang J; Luo X; Ihsan A; Liu X; Dai M; Cheng G; Hao H; Wang X; Yuan Z
Food Chem Toxicol; 2016 Jul; 93():145-57. PubMed ID: 27170491
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of Bacillus species-derived surfactin on Brachyspira hyodysenteriae and Clostridium perfringens.
Horng YB; Yu YH; Dybus A; Hsiao FS; Cheng YH
AMB Express; 2019 Nov; 9(1):188. PubMed ID: 31754906
[TBL] [Abstract][Full Text] [Related]
7. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides.
Wang X; Zhang H; Huang L; Pan Y; Li J; Chen D; Cheng G; Hao H; Tao Y; Liu Z; Yuan Z
Chem Res Toxicol; 2015 Mar; 28(3):470-81. PubMed ID: 25626015
[TBL] [Abstract][Full Text] [Related]
8. Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.
Cheng G; Sa W; Cao C; Guo L; Hao H; Liu Z; Wang X; Yuan Z
Front Pharmacol; 2016; 7():64. PubMed ID: 27047380
[TBL] [Abstract][Full Text] [Related]
9. Advances in Metabolism and Metabolic Toxicology of Quinoxaline 1,4-Di-N-oxides.
An H; Li Y; Li Y; Gong S; Zhu Y; Li X; Zhou S; Wu Y
Chem Res Toxicol; 2024 Apr; 37(4):528-539. PubMed ID: 38507288
[TBL] [Abstract][Full Text] [Related]
10. The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview.
Liu ZY; Sun ZL
Med Chem; 2013 Dec; 9(8):1017-27. PubMed ID: 23521002
[TBL] [Abstract][Full Text] [Related]
11. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1,4-di-N-oxide scaffold.
Agrawal N; Bhardwaj A
Chem Biol Drug Des; 2022 Sep; 100(3):346-363. PubMed ID: 35610776
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo.
Ihsan A; Wang X; Zhang W; Tu H; Wang Y; Huang L; Iqbal Z; Cheng G; Pan Y; Liu Z; Tan Z; Zhang Y; Yuan Z
Food Chem Toxicol; 2013 Sep; 59():207-14. PubMed ID: 23774262
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial activities of animal-used quinoxaline 1,4-di-N-oxides against mycobacteria, mycoplasma and fungi.
Zhao Y; Cheng G; Hao H; Pan Y; Liu Z; Dai M; Yuan Z
BMC Vet Res; 2016 Sep; 12(1):186. PubMed ID: 27600955
[TBL] [Abstract][Full Text] [Related]
14. Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs.
Gali-Muhtasib HU; Haddadin MJ; Rahhal DN; Younes IH
Oncol Rep; 2001; 8(3):679-84. PubMed ID: 11295102
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide against E. histolytica and their analysis as potential thioredoxin reductase inhibitors.
Soto-Sánchez J; Caro-Gómez LA; Paz-González AD; Marchat LA; Rivera G; Moo-Puc R; Arias DG; Ramírez-Moreno E
Parasitol Res; 2020 Feb; 119(2):695-711. PubMed ID: 31907668
[TBL] [Abstract][Full Text] [Related]
16. Determination of marker residues of quinoxaline-1,4-di-N-oxides and its prototype identification by liquid chromatography tandem mass spectrometry.
Li L; Liu R; Liu L; Guo Z; Zhou T; Yang Y; Yang H; He L
Food Chem; 2024 Jun; 442():138395. PubMed ID: 38266409
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C induction of bacteriophages from Serpulina hyodysenteriae and Serpulina innocens.
Humphrey SB; Stanton TB; Jensen NS
FEMS Microbiol Lett; 1995 Dec; 134(1):97-101. PubMed ID: 8593962
[TBL] [Abstract][Full Text] [Related]
18. High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.
Wang X; Yang C; Ihsan A; Luo X; Guo P; Cheng G; Dai M; Chen D; Liu Z; Yuan Z
Toxicology; 2016 Feb; 341-343():1-16. PubMed ID: 26802905
[TBL] [Abstract][Full Text] [Related]
19. Identification of genes associated with prophage-like gene transfer agents in the pathogenic intestinal spirochaetes Brachyspira hyodysenteriae, Brachyspira pilosicoli and Brachyspira intermedia.
Motro Y; La T; Bellgard MI; Dunn DS; Phillips ND; Hampson DJ
Vet Microbiol; 2009 Mar; 134(3-4):340-5. PubMed ID: 18950961
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes of VSH-1, a prophage-like gene transfer agent of Brachyspira hyodysenteriae.
Matson EG; Thompson MG; Humphrey SB; Zuerner RL; Stanton TB
J Bacteriol; 2005 Sep; 187(17):5885-92. PubMed ID: 16109929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
